Panobinostat, sold under the brand name Farydak, is a medication used for the treatment of multiple myeloma. It is a hydroxamic acid and acts as a non-selective histone deacetylase inhibitor (pan-HDAC inhibitor).
{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 455315413 | image = Panobinostat.svg | image_class = skin-invert-image | width = 275 | alt =
| pronounce = | tradename = Farydak | Drugs.com = | DailyMedID = Panobinostat | pregnancy_AU = | pregnancy_category = | routes_of_administration = By mouth | ATC_prefix = L01 | ATC_suffix = XH03 | ATC_supplemental =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).